Market Research Logo

Moldova Pharmaceuticals & Healthcare Q4 2018

Moldova Pharmaceuticals & Healthcare Q4 2018

Key View:

Moldova's operating environment remains unattractive to pharmaceutical companies. The small market size with limitedgrowth potential for high value medicines will discourage drugmakers from investing in the country. Moreover, high levels ofindustry- and country-specific risks, such as an uncertain pricing regime and high political risk, will augment the challenges faced bycompanies marketing their products in Moldova.


Key View
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Prescription Drug Market Forecast
Patented Drug Market Forecast
Generic Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Central And Eastern Europe Innovative Pharmaceuticals Risk/Reward Index
Moldova Pharmaceuticals & Healthcare Risk/Reward Index
Regulatory Development
Regulatory Review
Market Overview
Competitive Landscape
Company Profile
Farmaco (Pharmaco)
Moldova Demographic Outlook
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report